Abstract-The hypotensive action of CV-4093.2HC1 (CV-4093), a new calcium antagonist, was studied in spontaneously hypertensive, renal hypertensive, DOCA salt hypertensive and normotensive rats. CV-4093 (3 and 10 mg/kg, p.o.) dose dependently decreased systolic blood pressure in the three types of hypertensive rats. At the dose of 10 mg/kg, the compound decreased the blood pressure to the normotensive level between 1 and 3 hr after it was administered; the antihypertensive effect lasted for at least 8 hr. The systolic blood pressure in normotensive rats was also decreased at 3 and 10 mg/kg, p.o., but less evidently than in the hypertensive rats. When the antihypertensive effect of CV-4093 was compared with that of seven known calcium antagonists in spontaneously hypertensive rats, it was the most potent and the most long-lasting.
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Calcium antagonists interfere with the excitation-contraction coupling mechanism in smooth and cardiac muscle by decreasing the influx of Ca2+ (1). They reduce the con tractile activity of the heart, and prompt coronary and systemic vasodilation. Since this latter effect reduces elevated blood pressure, calcium antagonists are now being used clinically to treat hypertension (2, 3).
CV-4093.2HCI (CV-4093), methyl 2-(4 diphenylmethyl-1 -piperazinyl)ethyl (±)-1,4 dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5 pyridinedicarboxylate dihydrochloride, is a new calcium antagonist (4). CV-4093 has long-lasting inhibitory actions on calcium currents in smooth muscle cells of the rabbit pulmonary artery (5), and it shows an anti hypertensive action without a decrease in cardiac output in spontaneously hyper tensive rats of stroke-prone strain (SHR) (6). In the present report, the effect of CV-4093 on blood pressure was studied in three types of experimental hypertension: SHR, deoxy corticosterone acetate (DOCA)-salt hyper tensive rats and renal hypertensive rats. The hypotensive effect of CV-4093 was compared with that of seven known calcium antagonists in SHR.
Materials and Methods
Animals: Normotensive male Wistar-Kyoto rats, 10 weeks of age, and male stroke-prone SHR, 9-11 weeks of age, were used. The source of the SHR has been reported elsewhere (7). Renal hypertensive rats (two kidney, one-clip Goldblatt type) were pro duced by the following method: Under ether anesthesia, the left renal artery of male Wistar-Kyoto rats (6 weeks of age) was clamped by a silver ribbon (slit width, 0.23 mm). Systolic blood pressure was measured once a week. Rats with a systolic blood pressure of 170-200 mmHg were used between 3 and 4 weeks after surgery. DOCA salt hypertensive rats were produced by the following procedures: The left kidney of male Wistar-Kyoto rats (7 weeks of age) was removed under pentobarbital anesthesia (50 mg/kg, i.p.). The animals were maintained on a 1 % NaCI solution as drinking water and subcutaneously injected with 5 mg/kg DOCA suspended in 5% arabic gum once a week. Those with a systolic blood pressure of 170 200 mmHg were used between 3 and 5 weeks after surgery. Measurement of systolic blood pressure:
Systolic blood pressure in the tail artery was measured using a pulse pick-up method (7). The initial blood pressure was measured in the afternoon of the day before the experi ment. The changes in systolic blood pressure were measured 1, 3, 5, 8 and 24 hr after the calcium antagonists were administered. Drugs: CV-4093, nicardipine•HCI (nicardi pine), nifedipine, nimodipine, felodipine, diltiazem-HCI (diltiazem), verapamil•HCI (verapamil) and cinnarizine were synthesized in our Central Research Division. All drugs, except verapamil which was dissolved in saline, were suspended in 5% arabic gum. All were given orally.
Statistical analysis: The ED20 value, which is the dose required to decrease systolic blood pressure of the rats by 20% of the related initial value, was calculated by regression analysis. Statistical differences were evaluated using two-way analysis of variance followed by Scheffe's test. The hypotensive effect of the highest dose lasted for at least 8 hr. The antihypertensive effects of CV-4093 on the three types of hypertensive rats were compared with those of nicardipine ( Table  2 ). Both drugs decreased the systolic pressure in a dose-dependent manner. The maximum effect of 10 mg/kg of CV-4093 was observed between 1 and 3 hr, and the hypotensive action lasted until at least 8 hr after it was administered in the three types of hyper tensive rats. When the anti hypertensive effects were compared at the same dose, CV-4093 was more potent than nicardipine in all three models. The ED20 values of CV-4093 were 2.3, 2.4, 3.0 and 4.3 mg/kg in renal hyper tensive, DOCA-salt hypertensive, SHR and normotensive rats, respectively.
Comparison with known calcium an tagonists: The hypotensive action of CV 4093 was compared with that of seven known calcium antagonists including nicardipine in SHR (Tables  2 and 3 ). The dose-de pendencies of the hypotensive effects of the drugs are summarized in Fig. 1 . All com pounds, except cinnarizine, dose-depen dently decreased systolic blood pressure. Cinnarizine did not reduce blood pressure. The calculated ED20 values were as follows: CV-4093, 3.0; felodipine, 4.4; nifedipine, 5.6; nicardipine, 10.4; nimodipine, 28.0; verapa mil, 33.2; diltiazem, 100 mg/kg. CV-4093 and verapamil showed more persistent action than the others when the duration of hypotensive action was compared at the dose which reduced the systolic pressure by 15-19% of the related initial value 1 hr after the drugs were administered (Table 4) . The action of CV-4093 (3 mg/kg) and verapamil (30 mg/kg) persisted for at least 8 hr; the actions of nimodipine (30 mg/kg) and diltiazem (100 mg/kg) diminished within 8 hr; and the actions of felodipine (3 mg/kg), nifedipine (5 mg/kg) and nicardipine (10 mg/kg) diminished within 5 hr. 
Discussion
The contractility of smooth muscle depends on the intracellular Ca2+ ions to activate myofibrillar ATPase which generates the contractile energy (8-10). Not only a greater responsiveness to added Ca2+ and higher membrane permeability to Ca2+ in the arteries (11, 12) but also an increase in calcium con tents of cardiovascular tissues (13, 14) have been reported in experimental hypertensive animals. These findings suggest that intra cellular Ca2+ is greatly involved in the de velopment of hypertension and that a new calcium antagonist that selectively acts on resistance vessels will be useful for treating hypertension.
Recently, Nakaya et al. (15) Toxicol. 20, 346-352 (1982) 
